BD and Biodiversity collaborate on infection tests for transplant patients
This article was originally published in Clinica
Executive Summary
Privately-held Italian biotech firm Biodiversity is teaming up with BD Diagnostics to develop and commercialise a menu of molecular diagnostics for immunocompromised patients which will run on the BD Max system. Biodiversity will develop the tests, which will be designed to improve the monitoring of infections in transplant recipients who are at high risk because of the immunosuppressant drugs needed to prevent transplant rejection. The assays produced through the collaboration are intended to be CE marked for sale in Europe initially – this could later be expanded to include approval in other countries and regions, according to the companies. BD Diagnostics, part of Becton Dickinson, is currently expanding the menu for its automated BD Max system, and there are currently 15 tests in the pipeline. Earlier this month, the company agreed to develop a BD Max test for Aspergillus infection with personalised medicine specialist Lab21.
You may also be interested in...
What are the hottest innovations from Israel?
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
EuroPCR: St Jude and Philips talk up rival intravascular imaging techs
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
EuroPCR: Medtronic's drug-coated balloon keeps rising
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.